101 related articles for article (PubMed ID: 20090458)
21. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
Basu S; Li G; Bural G; Alavi A
Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
[TBL] [Abstract][Full Text] [Related]
22. F-18 FDG PET/CT detecting thyroid plasmacytoma after the successful treatment of gastric large B-cell lymphoma.
Shahani S; Ahmad A; Barakat FH; Chuang HH; Fowler NH; Myers JN; Stava C; Habra MA
Clin Nucl Med; 2011 Apr; 36(4):317-9. PubMed ID: 21368613
[No Abstract] [Full Text] [Related]
23. 18F-FDG PET in the management of patients with anaplastic thyroid carcinoma.
Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Kasperbauer JL; Reading CC; Hay ID; Lowe VJ
Thyroid; 2008 Jul; 18(7):713-9. PubMed ID: 18630999
[TBL] [Abstract][Full Text] [Related]
24. F-18 FDG-PET/CT evaluation of patients with differentiated thyroid cancer with negative I-131 total body scan and high thyroglobulin level.
Bertagna F; Bosio G; Biasiotto G; Rodella C; Puta E; Gabanelli S; Lucchini S; Merli G; Savelli G; Giubbini R; Rosenbaum J; Alavi A
Clin Nucl Med; 2009 Nov; 34(11):756-61. PubMed ID: 19851169
[TBL] [Abstract][Full Text] [Related]
25. Imaging in endocrinology: 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in differentiated thyroid carcinoma: clinical indications and controversies in diagnosis and follow-up.
Salvatori M; Biondi B; Rufini V
Eur J Endocrinol; 2015 Sep; 173(3):R115-30. PubMed ID: 25947140
[TBL] [Abstract][Full Text] [Related]
26. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging.
Chiang SB; Rebenstock A; Guan L; Alavi A; Zhuang H
Clin Nucl Med; 2003 Aug; 28(8):674-6. PubMed ID: 12897658
[TBL] [Abstract][Full Text] [Related]
27. Detection of thyroid plasmacytoma by F-18 FDG PET/CT imaging.
Ozkan E; Tokmak E; Kir KM
Clin Nucl Med; 2008 Apr; 33(4):292-3. PubMed ID: 18356675
[TBL] [Abstract][Full Text] [Related]
28. Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies.
Teo BK; Badiee S; Hadi M; Lam T; Johnson L; Seo Y; Bacharach SL; Hasegawa BH; Franc BL
Nucl Med Commun; 2008 Apr; 29(4):359-66. PubMed ID: 18317301
[TBL] [Abstract][Full Text] [Related]
29. Interesting image. F-18 FDG PET images of uterine cervical cancer producing granulocyte colony stimulating factor.
Koyama M; Hayasaka K; Takeshima N; Machida H; Takizawa K
Clin Nucl Med; 2010 Nov; 35(11):902-3. PubMed ID: 20940557
[No Abstract] [Full Text] [Related]
30. (18)F-fluorodeoxyglucose positron emission tomography to assess response after radiation therapy in anaplastic thyroid cancer.
Levy A; Leboulleux S; Lepoutre-Lussey C; Baudin E; Ghuzlan AA; Hartl D; Deutsch E; Deandreis D; Lumbroso J; Tao Y; Schlumberger M; Blanchard P
Oral Oncol; 2015 Apr; 51(4):370-5. PubMed ID: 25595614
[TBL] [Abstract][Full Text] [Related]
31. A rare case of thyroid paraganglioma detected by ¹⁸F-FDG PET/CT.
Treglia G; Giovanella L; Caldarella C; Bertagna F
Rev Esp Med Nucl Imagen Mol; 2014; 33(5):320-1. PubMed ID: 24559939
[No Abstract] [Full Text] [Related]
32. Metastatic malignant melanoma to the thyroid gland detected by FDG-PET imaging.
Basu S; Alavi A
Clin Nucl Med; 2007 May; 32(5):388-9. PubMed ID: 17452870
[No Abstract] [Full Text] [Related]
33. FDG uptake in metastatic spreading mucoepidermoid carcinoma of the thyroid.
Wissmeyer M; Weidner S; Muggli B; Weimann R; Juengling FD; Krause T
Clin Nucl Med; 2007 May; 32(5):383-7. PubMed ID: 17452869
[No Abstract] [Full Text] [Related]
34. [An autopsy of G-CSF-producing anaplastic carcinoma of the pancreas with impaired accumulation on FDG-PET after S-1 chemotherapy].
Ikeda S; Okubo K; Shibahara H; Narita M; Morita K; Takeuchi A; Kanazawa H; Ito T; Nishimura D; Katada N
Gan To Kagaku Ryoho; 2013 Jun; 40(6):789-92. PubMed ID: 23863660
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic accuracy and prognostic value of 18F-FDG PET in Hürthle cell thyroid cancer patients.
Pryma DA; Schöder H; Gönen M; Robbins RJ; Larson SM; Yeung HW
J Nucl Med; 2006 Aug; 47(8):1260-6. PubMed ID: 16883003
[TBL] [Abstract][Full Text] [Related]
36. Detection of papillary thyroid cancer brain metastasis with FDG-PET/CT.
Rini JN; Nguyen VT; Ben-Levi E; Naidich JJ; Yi Li J; Palestro CJ
Clin Nucl Med; 2010 May; 35(5):357-9. PubMed ID: 20395715
[No Abstract] [Full Text] [Related]
37. F-18 FDG PET/CT imaging of a subcutaneous scalp metastasis from primary carcinoma of the thyroid.
Niederkohr RD; Dadras SS; Leavitt M; McDougall IR
Clin Nucl Med; 2007 Feb; 32(2):162-4. PubMed ID: 17242580
[No Abstract] [Full Text] [Related]
38. FDG PET/CT for assessing therapy response in primary thyroid lymphoma.
Lin EC
Clin Nucl Med; 2007 Feb; 32(2):152-3. PubMed ID: 17242576
[No Abstract] [Full Text] [Related]
39. Primary thyroid osteosarcoma: staging and evaluation of response to therapy with F-18 FDG PET-CT.
Makis W; Novales-Diaz JA; Hickeson M
Clin Nucl Med; 2010 Jul; 35(7):517-20. PubMed ID: 20548146
[No Abstract] [Full Text] [Related]
40. Value of Fluorodeoxyglucose PET/Computed Tomography Patient Management and Outcomes in Thyroid Cancer.
Ciarallo A; Marcus C; Taghipour M; Subramaniam RM
PET Clin; 2015 Apr; 10(2):265-78. PubMed ID: 25829091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]